Literature DB >> 22796021

Body fat changes and mitochondrial alterations during HBV treatment: a warning for long term administration.

Giordano Madeddu, Andrea Soddu, Franca Mannu, Alberto A Muredda, Giovanni Garrucciu, Franco Bandiera, Salvatore Zaru, Maria Stella Mura, Sergio Babudieri.   

Abstract

Mesh：

Substances：

Year:  2012        PMID： 22796021     DOI： 10.1016/j.jinf.2012.07.002

Source DB:  PubMed          Journal:  J Infect        ISSN： 0163-4453            Impact factor:   6.072


× No keyword cloud information.
  3 in total

1.  Cumulative incidence and risk factors of creatine kinase elevation associated with telbivudine.

Authors:  Li Chen; Cai Cheng; Bicui Chen; Yue Zhao; Jiming Zhang; Bin Wang
Journal:  Eur J Clin Pharmacol       Date:  2015-11-14       Impact factor: 2.953

2.  Mitochondrial toxicity and body shape changes during nucleos(t)ide analogues administration in patients with chronic hepatitis B.

Authors:  Giordano Madeddu; Vito Fiore; Michela Melis; Silvia Ortu; Franca Mannu; Alberto Augusto Muredda; Giovanni Garrucciu; Franco Bandiera; Salvatore Zaru; Paola Bagella; Diego Francesco Calvisi; Sergio Babudieri
Journal:  Sci Rep       Date:  2020-02-06       Impact factor: 4.379

3.  Metabolic-associated fatty liver disease is associated with low muscle mass and strength in patients with chronic hepatitis B.

Authors:  Cecy Maria de Lima Santos; Matheus Duarte Brito; Pedro Alves Soares Vaz de Castro; Thais Pontello de Vries; Nataly Lopes Viana; Marta Paula Pereira Coelho; Olívio Brito Malheiro; Tatiana Bering; Maria Cristina Gonzalez; Rosângela Teixeira; Rodrigo Dias Cambraia; Gifone Aguiar Rocha; Luciana Diniz Silva
Journal:  World J Hepatol       Date:  2022-08-27
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.